Clinical Trial Update: Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis [NA]

View source ↗

Summary

ClinicalTrials.gov update on a terminated study evaluating procalcitonin-guided antimicrobial use in critically ill cancer patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Sepsis
• Septic Shock

Snippet

Sponsor: King Hussein Cancer Center | Conditions: Sepsis, Septic Shock | NA | Status: TERMINATED